The public health implications are huge. If we give chemotherapy only to breast cancer patients at high risk for recurrence, we can avoid overtreating.
from Forbes Real Time https://www.forbes.com/sites/elaineschattner/2018/06/03/many-breast-cancer-patients-can-safely-skip-chemo-tailorx-trial-of-oncotype-test-confirms/
via IFTTT
No comments:
Post a Comment